Atlas Venture Associates XII LLC 13D and 13G filings for Aerovate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-11-05 4:38 pm Purchase |
2021-07-02 | 13D | Aerovate Therapeutics, Inc. AVTE |
Atlas Venture Associates XII LLC | 3,103,879 12.700% |
3,103,879 (New Position) |
Filing |